Skip to main content

Study

Taking Multiple Medications Increases Mortality Risk in Seniors

Using five or more prescription medications significantly raises the risk of mortality in older adults.

Medication ManagementHealthy AgingQuality of Life
Study Credibility: Medium5.6/10Some supporting evidenceStudy has limitationsUse with caution
PublishedSep 2026Last reviewedSep 2026
Email this

Summary

In plain language

A recent study found that seniors taking five or more prescription medications, a situation known as polypharmacy, have an increased risk of mortality. The research involved over 7,800 participants aged 65 and older, revealing that more than half experienced some form of high-risk medication use. However, only polypharmacy was consistently linked to a higher risk of death. This finding emphasizes the importance of reviewing medication regimens to ensure they are necessary and safe, potentially leading to better health outcomes for older adults. Seniors should discuss their medications with healthcare providers to consider the benefits of deprescribing unnecessary drugs.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study investigated the impact of high-risk medication use on mortality among seniors. Researchers followed participants from the National Health and Nutrition Examination Survey between 1999 and 2016. They specifically looked at polypharmacy, drug interactions, and inappropriate medications.

  • Polypharmacy, defined as using five or more medications, was linked to a 38% higher risk of mortality.

  • The study controlled for health factors like organ function, ensuring the results weren't skewed by participants' overall health status.

  • While other medication risks were considered, polypharmacy stood out as the most significant factor.

Seniors are encouraged to talk with their healthcare providers about simplifying medication regimens to improve safety and reduce health risks.

Research Quality Score

Scored September 16, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study is a well-conducted prospective cohort analysis using a large, nationally representative dataset. It scores well on statistical integrity due to robust analysis methods. However, it lacks randomization and blinding, impacting bias control. Transparency is limited by the absence of pre-registration or data sharing. The study is highly relevant to the target population and published in a high-quality journal. Conflicts of interest are disclosed, but indirect industry ties are noted.

Category Breakdown

CategoryScoreRating
Study design6.7/10
Bias control3.3/10
Statistical methods10.0/10
Reporting completeness5.0/10
Conflicts & funding5.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

The study investigates the association between higher-risk medication use and mortality in older adults using NHANES data. It finds that polypharmacy is independently associated with increased mortality risk, while drug-drug interactions and potentially inappropriate medications are not.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Conditions This Research Covers

These condition pages help connect the paper back to the real-world health concerns it addresses.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.